Chrysostomou S, Roy R, Prischi F, Thamlikitkul L, Chapman KL, Mufti U, Peach R, Ding L, Hancock D, Moore C, Molina-Arcas M, Mauri F, Pinato DJ, Abrahams JM, Ottaviani S, Castellano L, Giamas G, Pascoe J, Moonamale D, Pirrie S, Gaunt C, Billingham L, Steven NM, Cullen M, Hrouda D, Winkler M, Post J, Cohen P, Salpeter SJ, Bar V, Zundelevich A, Golan S, Leibovici D, Lara R, Klug DR, Yaliraki SN, Barahona M, Wang Y, Downward J, Skehel JM, Ali MMU, Seckl MJ, Pardo OE. Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer. Science Translational Medicine, July 2021 ,Vol 13, Issue 602
Pascoe, J., Jackson, A., Gaskell, C., Gaunt, C., Thompson, J., Billingham, L., & Steven, N. (2021). Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH). BMC Cancer, 21(1), [800]. https://doi.org/10.1186/s12885-021-08519-8
SMALL: Paper; Editorial. Morgan, J., Potter, S., Sharma, N., McIntosh, S. A., Coles, C. E., Dodwell, D., Elder, K., Gaunt, C., Lyburn, I. D., McIntosh, S. A., Morgan, J., Paramasivan, S., Pinder, S., Pirrie, S., Potter, S., Rea, D., Roberts, T., Sharma, N., Stobart, H., Taylor-Phillips, S., Wallis, M., Wilcox, M. The SMALL trial: A big change for small breast cancers. Clinical Oncology. 2019;31(9):659-63.
Cameron, D., Morden, J. P., Canney, P., Velikova, G., Coleman, R., Bartlett, J., Gaunt, C. et al. (2017). Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): A multicentre, phase 3, open-label, randomised, controlled trial. The Lancet.Oncology.
Coleman, R. E., Marshall, H., Cameron, D., DodwellL, D., Burkishaw, R., KeaneE, M., Gil, M., Houston, S. J., Grieve, R. J., Barrett-Lee, P. J., Ritchie, D., Pugh, J., Gaunt, C., Rea R., Peterson, J., Davies, C., Hiley, V., Gregory, W. & Bell, R. 2011. Breast-cancer adjuvant therapy with zoledronic acid. N Engl J Med, 365, 1396-405
Cullen MH, Billingham LJ, Gaunt CH, Steven NM. Rational selection of patients for antibacterial prophylaxis after chemotherapy. J Clin Oncol 2007 Oct 20;25(30):4821-8.
Innes H, Billingham L, Gaunt C, Steven N, Marshall E. Management of febrile neutropenia in the United Kingdom: time for a national trial? Br J Cancer 2005 Dec 12;93(12):1324-8.
Cullen M, Steven N, Billingham L, Gaunt C, Hastings M, Simmonds P, et al. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 2005 Sep 8;353(10):988-98.
Cullen MH, Billingham LJ, Gaunt CH, Steven NM. Rational selection of patients for antibacterial prophylaxis after chemotherapy. J Clin Oncol 2007 Oct 20;25(30):4821-8.